NCT00384280已完成1 期
An Open Label, 2-period, Sequential Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 24 人开始时间: 2006年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 主要终点
- To evaluate the effects of multiple oral doses of rifampin on the pharmacokinetic (PK) profile of a single oral dose of HCV-796 in healthy subjects.
研究概览
简要总结
An open label, 2-period, sequential study to determine the impact of multiple doses of rifampin on single-dose pharmacokinetics of HCV-796
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).
排除标准
- 未提供
结局指标
主要结局
To evaluate the effects of multiple oral doses of rifampin on the pharmacokinetic (PK) profile of a single oral dose of HCV-796 in healthy subjects.
次要结局
- To assess the safety and tolerability of HCV-796 and rifampin when coadministered to healthy subjects.
研究者
相似试验
已完成
1 期
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerHematologic MalignancyMalignant LymphomaNCT01324323Celgene14
撤回
1 期
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy ParticipantsHealthy ParticipantsNCT04558216Phathom Pharmaceuticals, Inc.
已完成
1 期
Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of DeflazacortHealthy VolunteersNCT02286635PTC Therapeutics58
已完成
1 期
A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922HealthyNCT02661893Janssen Research & Development, LLC14
已完成
1 期
Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of CamlipixantCoughHealthyNCT05899829Bellus Health Inc. - a GSK company42